| Orlando Alfonso Castillo, MD | |
|
1098 W Baltimore Pike, Suite 3303 Rmh Op Pavilion, Media, PA 19063-5139 | |
| (610) 532-1300 | |
| (610) 399-4675 |
| Full Name | Orlando Alfonso Castillo |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 1098 W Baltimore Pike, Media, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447250162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD 051044 L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Home Health | Springfield, PA | Home health agency |
| Mercy Catholic Medical Center- Mercy Fitzgerald | Darby, PA | Hospital |
| Chester County Hospital | West chester, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Entity Name | Orlando A. Castillo M.d. And Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386809077 PECOS PAC ID: 1254493398 Enrollment ID: O20081223000571 |
News Archive
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Today's headlines include a variety of stories that reflect how health policy issues are playing on the campaign trail.
Without addressing these gaps, collaboration between schools (operating under FERPA) and health departments (operating under HIPAA) can compromise student privacy.
GAVI Alliance's plan to introduce new vaccine projects in the developing world "is under threat amid the international economic downturn," the Financial Times reports. "Subsidies to extend the use of vaccines against rubella, HPV to tackle cervical cancer, cholera and Japanese encephalitis in the developing world are among those likely to be cancelled or delayed," according to GAVI's CEO Julian Lob-Levyt, the newspaper writes.
› Verified 9 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Today's headlines include a variety of stories that reflect how health policy issues are playing on the campaign trail.
Without addressing these gaps, collaboration between schools (operating under FERPA) and health departments (operating under HIPAA) can compromise student privacy.
GAVI Alliance's plan to introduce new vaccine projects in the developing world "is under threat amid the international economic downturn," the Financial Times reports. "Subsidies to extend the use of vaccines against rubella, HPV to tackle cervical cancer, cholera and Japanese encephalitis in the developing world are among those likely to be cancelled or delayed," according to GAVI's CEO Julian Lob-Levyt, the newspaper writes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Orlando Alfonso Castillo, MD 42 Strickland Way, Glen Mills, PA 19342-1667 Ph: (610) 532-1300 | Orlando Alfonso Castillo, MD 1098 W Baltimore Pike, Suite 3303 Rmh Op Pavilion, Media, PA 19063-5139 Ph: (610) 532-1300 |
News Archive
The National Institute of Environmental Health Sciences and the National Toxicology Program, part of the National Institutes of Health, will mark the 50th anniversary of the Society of Toxicology at the SOT annual meeting in Washington, D.C., March 6-10, 2011.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
Today's headlines include a variety of stories that reflect how health policy issues are playing on the campaign trail.
Without addressing these gaps, collaboration between schools (operating under FERPA) and health departments (operating under HIPAA) can compromise student privacy.
GAVI Alliance's plan to introduce new vaccine projects in the developing world "is under threat amid the international economic downturn," the Financial Times reports. "Subsidies to extend the use of vaccines against rubella, HPV to tackle cervical cancer, cholera and Japanese encephalitis in the developing world are among those likely to be cancelled or delayed," according to GAVI's CEO Julian Lob-Levyt, the newspaper writes.
› Verified 9 days ago
Dr. Vincent M Digiovanni, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1098 W Baltimore Pike, Suite 3308 Riddle Health Center 3, Media, PA 19063 Phone: 610-565-8564 Fax: 610-565-3046 | |
Dr. Hassan C Vakil, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1098 W Baltimore Pike, Ste 3411, Media, PA 19063 Phone: 610-565-4338 Fax: 610-565-3456 | |
Abdul Safi, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1068 W Baltimore Pike, Media, PA 19063 Phone: 610-891-3388 Fax: 610-891-3680 | |
Dr. Charles Allen Dallara, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1088 W Baltimore Pike, Suite 2507 Health Center 2, Media, PA 19063 Phone: 610-627-4427 Fax: 610-891-3417 | |
Sumedh Dilip Kakade, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1088 W Baltimore Pike Ste 2507, Media, PA 19063 Phone: 610-627-4427 Fax: 610-891-3417 | |
Roque Guerzon, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1068 W Baltimore Pike, Media, PA 19063 Phone: 610-891-3388 Fax: 610-891-3680 |